URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO, Sverdlovsk Oblast

Economic indicators

Net profit (RAS) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO dropped in 2021 10.28 times to 2.94 million RUB from 30.24 million RUB over the same period in 2020, the company informed.

Revenue decreased in the accounting period 3.87 times to 6.21 million RUB from 24.02 million RUB in 2020; cost of goods sold grew by 1.26% to 1.52 million RUB from 1.50 million RUB; sales loss decreased by 30.93% to 41.60 million RUB from 60.23 million RUB.

Net profit (RAS) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO made up 30.24 million RUB over 2020 compared to net loss of 72.56 million RUB over 2019, the company informed.

Revenue decreased in the accounting period by 41.93% to 24.02 million RUB from 41.36 million RUB in 2019; cost of goods sold decreased by 38.06% to 1.50 million RUB from 2.43 million RUB; sales loss decreased by 44.67% to 60.23 million RUB from 108.84 million RUB.

Net loss (RA) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO made up 72.56 million RUB over 2019 compared to net profit of 27.52 million RUB over 2018, the company informed.

Revenue decreased in the accounting period 3.00 times to 41.36 million RUB from 124.00 million RUB in 2018; cost of goods sold decreased 51.13 times to 2.43 million RUB from 124.14 million RUB; sales loss grew 4.83 times to 108.84 million RUB from 22.53 million RUB.

Net profit (RAS) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO grew over 2018 2.20 times to 27.52 million RUB from 12.52 million RUB over 2017, the company informed.

Revenue increased in the accounting period by 4.28% to 124.00 million RUB from 118.91 million RUB over 2017; cost of goods sold decreased by 6.04% to 124.14 million RUB from 132.12 million RUB; sales loss decreased by 33.94% to 22.53 million RUB from 34.11 million RUB.

Net profit (RAS) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO grew over 2016 2.91 times to 13.68 million RUB from 4.71 million RUB over 2015, the company informed.

Revenue increased in the accounting period 2.28 times to 108.03 million RUB from 47.45 million RUB over 2015; cost of goods sold grew by 16.36% to 123.38 million RUB from 106.04 million RUB; sales loss decreased by 48.53% to 36.35 million RUB from 70.62 million RUB.

Net profit (RAS) of URAL'SKIY TSENTR BIOFARMATSEVTICHESKIKH TEKHNOLOGIY, OOO made up 98.67 million RUB over 2014 compared to net loss of 5.17 million RUB over 2013, the company informed.

Cost of goods sold grew 5.59 times to 16.46 million RUB from 2.95 million RUB; sales loss decreased 2.50 times to 1.18 million RUB from 2.95 million RUB.

Companies in the region

• TK VEST
• FINUPRAVLENIE ADMINISTRATSII KAMYSHLOVSKOGO GO
• NAUMEN SOFT
• FORTUNA
• KONSTI